HCA Healthcare, Inc. $HCA Shares Sold by Park National Corp OH

Key Points

• Park National Corp OH cut its stake in HCA by 19.6% in Q4, selling 5,653 shares and leaving it with 23,201 shares valued at about $10.83 million.
• HCA beat Q4 EPS expectations ($8.01 vs. $7.37), reported 6.7% revenue growth year‑over‑year and set FY2026 guidance of 29.10–31.50 EPS, while analysts raised price targets and the consensus rating is a Moderate Buy with a $537.73 target.
• Over the past 90 days insiders sold 15,214 shares (~$7.8M), and the company raised its quarterly dividend to $0.78 (annualized $3.12, yield ~0.6%).

Park National Corp OH decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 19.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,201 shares of the company's stock after selling 5,653 shares during the quarter. Park National Corp OH's holdings in HCA Healthcare were worth $10,832,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in HCA. Sovran Advisors LLC grew its holdings in shares of HCA Healthcare by 1.0% during the third quarter. Sovran Advisors LLC now owns 2,278 shares of the company's stock worth $1,063,000 after buying an additional 22 shares during the last quarter. Centerpoint Advisors LLC lifted its position in HCA Healthcare by 11.0% during the 3rd quarter. Centerpoint Advisors LLC now owns 222 shares of the company's stock worth $95,000 after acquiring an additional 22 shares during the period. Cary Street Partners Financial LLC increased its holdings in shares of HCA Healthcare by 3.9% in the third quarter. Cary Street Partners Financial LLC now owns 590 shares of the company's stock valued at $251,000 after purchasing an additional 22 shares during the period. Angeles Wealth Management LLC lifted its holdings in shares of HCA Healthcare by 2.4% during the third quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company's stock worth $432,000 after purchasing an additional 24 shares during the period. Finally, One Capital Management LLC increased its stake in HCA Healthcare by 1.1% in the 3rd quarter. One Capital Management LLC now owns 2,250 shares of the company's stock valued at $959,000 after buying an additional 24 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

HCA has been the topic of several analyst reports. Barclays lifted their target price on shares of HCA Healthcare from $494.00 to $551.00 and gave the company an "overweight" rating in a report on Wednesday, January 28th. The Goldman Sachs Group lifted their price objective on HCA Healthcare from $520.00 to $558.00 and gave the company a "buy" rating in a report on Wednesday, January 28th. Leerink Partners increased their target price on HCA Healthcare from $507.00 to $573.00 and gave the stock an "outperform" rating in a research note on Wednesday, January 28th. Robert W. Baird upped their price objective on HCA Healthcare from $423.00 to $450.00 and gave the stock a "neutral" rating in a report on Thursday, December 11th. Finally, Cantor Fitzgerald restated an "overweight" rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. Sixteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of "Moderate Buy" and a consensus target price of $537.73.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $499.49 on Friday. The stock has a market cap of $111.67 billion, a PE ratio of 17.60, a P/E/G ratio of 1.54 and a beta of 1.34. HCA Healthcare, Inc. has a 1 year low of $314.43 and a 1 year high of $556.52. The stock has a fifty day moving average price of $509.58 and a 200 day moving average price of $472.46.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating analysts' consensus estimates of $7.37 by $0.64. The business had revenue of $19.51 billion during the quarter, compared to analysts' expectations of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business's revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter last year, the business posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a $0.78 dividend. This is a boost from HCA Healthcare's previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Tuesday, March 17th. HCA Healthcare's dividend payout ratio (DPR) is currently 10.99%.

Insider Buying and Selling

In related news, SVP Jennifer Berres sold 8,020 shares of HCA Healthcare stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the sale, the senior vice president owned 11,993 shares in the company, valued at approximately $6,171,357.94. This trade represents a 40.07% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of the company's stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the transaction, the senior vice president owned 44,379 shares in the company, valued at approximately $22,411,395. This trade represents a 8.27% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 15,214 shares of company stock valued at $7,797,595. 1.30% of the stock is currently owned by company insiders.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.